Literature DB >> 27595766

Structural studies on KijD1, a sugar C-3'-methyltransferase.

Garrett T Dow1, James B Thoden1, Hazel M Holden1.   

Abstract

Kijanimicin is an antitumor antibiotic isolated from Actinomadura kijaniata. It is composed of three distinct moieties: a pentacyclic core, a monosaccharide referred to as d-kijanose, and a tetrasaccharide chain composed of l-digitoxose units. d-Kijanose is a highly unusual nitro-containing tetradeoxysugar, which requires at least ten enzymes for its production. Here we describe a structural analysis of one of these enzymes, namely KijD1, which functions as a C-3'-methyltransferase using S-adenosylmethionine as its cofactor. For this investigation, two ternary complexes of KijD1, determined in the presence of S-adenosylhomocysteine (SAH) and dTDP or SAH and dTDP-3-amino-2,3,6-trideoxy-4-keto-3-methyl-d-glucose, were solved to 1.7 or 1.6 Å resolution, respectively. Unexpectedly, these structures, as well as additional biochemical analyses, demonstrated that the quaternary structure of KijD1 is a dimer. Indeed, this is in sharp contrast to that previously observed for the sugar C-3'-methyltransferase isolated from Micromonospora chalcea. By the judicious use of site-directed mutagenesis, it was possible to convert the dimeric form of KijD1 into a monomeric version. The quaternary structure of KijD1 could not have been deduced based solely on bioinformatics approaches, and thus this investigation highlights the continuing need for experimental validation.
© 2016 The Protein Society.

Entities:  

Keywords:  Actinomadura kijaniata; C-3′-methyltransferase; antitumor antibiotic; d-kijanose; d-tetronitrose; kijanimicin

Mesh:

Substances:

Year:  2016        PMID: 27595766      PMCID: PMC5119555          DOI: 10.1002/pro.3034

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  16 in total

Review 1.  Alpha/beta hydrolase fold enzymes: the family keeps growing.

Authors:  M Nardini; B W Dijkstra
Journal:  Curr Opin Struct Biol       Date:  1999-12       Impact factor: 6.809

2.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

3.  Molecular architecture of a C-3'-methyltransferase involved in the biosynthesis of D-tetronitrose.

Authors:  Nathan A Bruender; James B Thoden; Manpreet Kaur; Marie K Avey; Hazel M Holden
Journal:  Biochemistry       Date:  2010-07-20       Impact factor: 3.162

4.  Surface, subunit interfaces and interior of oligomeric proteins.

Authors:  J Janin; S Miller; C Chothia
Journal:  J Mol Biol       Date:  1988-11-05       Impact factor: 5.469

5.  Probing the catalytic mechanism of a C-3'-methyltransferase involved in the biosynthesis of D-tetronitrose.

Authors:  Nathan A Bruender; Hazel M Holden
Journal:  Protein Sci       Date:  2012-04-24       Impact factor: 6.725

6.  Elucidation of the kijanimicin gene cluster: insights into the biosynthesis of spirotetronate antibiotics and nitrosugars.

Authors:  Hua Zhang; Jess A White-Phillip; Charles E Melançon; Hyung-jin Kwon; Wei-luen Yu; Hung-wen Liu
Journal:  J Am Chem Soc       Date:  2007-11-07       Impact factor: 15.419

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Kijanimicin (Sch 25663), a novel antibiotic produced by Actinomadura kijaniata SCC 1256. Fermentation, isolation, characterization and biological properties.

Authors:  J A Waitz; A C Horan; M Kalyanpur; B K Lee; D Loebenberg; J A Marquez; G Miller; M G Patel
Journal:  J Antibiot (Tokyo)       Date:  1981-09       Impact factor: 2.649

Review 9.  Spirotetronate polyketides as leads in drug discovery.

Authors:  Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  J Nat Prod       Date:  2014-12-01       Impact factor: 4.050

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.